Chronic kidney disease is a public health epidemic affecting millions. The toll to health care, our communities and to individuals is profound. Chronic kidney disease and is characterized by chronic inflammation, parenchymal cell loss and fibrosis. However the kidney when injured has enormous capacity for recovery. Understanding the mechanisms of normal recovery and how they differ from progressive inflammation in the kidney will lead to new therapies. We have been studying the role of macrophages, cells of the immune system recruited to the kidney, in regulating the normal repair process in the kidney and in directing the development of fibrosis, which is a harbinger of kidney failure. We have discovered that the Canonical WNT cell-to-cell signaling pathway, that regulates cell survival, differentiation, migration, proliferation and apoptosis, once thought to be restricted to paracrine cell communications of embryonic development and cancer, is active during kidney repair and also during kidney fibrosis. Our central hypothesis supported by extensive preliminary data is that inflammatory macrophages in the kidney release soluble ligands (WNTs) that signal via WNT receptors on paracrine cells and that this signaling plays an important role in mediating kidney repair. However when injury is persistent, WNT signaling from inflammatory macrophages supports the increase in interstitial fibroblasts and directs generation of scar tissue.
In AIM 1 we will focus on normal kidney repair following injury. We will examine the precise role of inflammatory macrophages and dissect a supporting role from epithelial cells in delivering WNT signals to neighboring cells of the kidney. We will use genetic approaches in the mouse to study: the effect of conditional ablation of macrophages in vivo on WNT signaling;the importance of WNT receptors Frizzled-4, Lrp-5 and Lrp-6 in kidney repair;and the role of macrophage Wnt-7b or the Wnt ligand release protein Wntless in vivo, in repair. We will administer soluble modulators of WNT signaling to affect repair of the kidney.
In AIM 2 we will focus Macrophage delivered WNT signaling on the progression of fibrosis in the kidney. Using genetic approaches in the mouse we will study the role of fibroblast WNT receptor Frizzled-7;the macrophage Wnt ligand release protein Wntless;and the transcriptional regulator ?-catenin in fibroblasts, on fibrosis progression in vivo. We will test the impact of soluble WNT modulators including Dickkopf-1 and -2 on fibrosis progression. Relevance: The overall purpose of these studies is to determine the roles of Canonical WNT signaling from macrophages, particularly to epithelial cells in normal kidney repair, but also to fibroblasts in the development of fibrosis. By understanding the mechanisms by which macrophages regulate injury and repair in the kidney we will develop new therapeutic paradigms that support normal repair, and counteract fibrosis in humans.

Public Health Relevance

Chronic kidney disease is a public health epidemic that affects millions yet the kidney has an enormous capacity for recovery. We have been studying a cell of the immune system called the macrophage that is recruited to the injured kidney and plays roles in both progression to kidney failure but also plays a role in normal repair. We have discovered that a cell-cell communication signaling pathway called WNT signaling, previously demonstrated to be pivotal in cancer progression and in normal embryonic development is active in the injured kidney and is used by macrophages in the kidney to direct repair of the cells of the kidney. We will study the molecular components of this complex cell-cell signaling pathway to discover new targets that may lead to new therapies for patients with kidney disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK084077-06
Application #
8466959
Study Section
Pathobiology of Kidney Disease Study Section (PBKD)
Program Officer
Hoshizaki, Deborah K
Project Start
2009-09-01
Project End
2014-05-31
Budget Start
2013-06-01
Budget End
2014-05-31
Support Year
6
Fiscal Year
2013
Total Cost
$341,480
Indirect Cost
$135,769
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Ieronimakis, Nicholas; Hays, Aislinn; Prasad, Amalthiya et al. (2016) PDGFRα signalling promotes fibrogenic responses in collagen-producing cells in Duchenne muscular dystrophy. J Pathol 240:410-424
Nakagawa, Naoki; Xin, Cuiyan; Roach, Allie M et al. (2015) Dicer1 activity in the stromal compartment regulates nephron differentiation and vascular patterning during mammalian kidney organogenesis. Kidney Int 87:1125-40
Pippin, Jeffrey W; Kaverina, Natalya V; Eng, Diana G et al. (2015) Cells of renin lineage are adult pluripotent progenitors in experimental glomerular disease. Am J Physiol Renal Physiol 309:F341-58
Kawakami, Takahisa; Gomez, Ivan G; Ren, Shuyu et al. (2015) Deficient Autophagy Results in Mitochondrial Dysfunction and FSGS. J Am Soc Nephrol 26:1040-52
Pippin, Jeffrey W; Glenn, Sean T; Krofft, Ronald D et al. (2014) Cells of renin lineage take on a podocyte phenotype in aging nephropathy. Am J Physiol Renal Physiol 306:F1198-209
Chen, Yi-Ting; Chang, Yu-Ting; Pan, Szu-Yu et al. (2014) Lineage tracing reveals distinctive fates for mesothelial cells and submesothelial fibroblasts during peritoneal injury. J Am Soc Nephrol 25:2847-58
Shankland, Stuart J; Pippin, Jeffrey W; Duffield, Jeremy S (2014) Progenitor cells and podocyte regeneration. Semin Nephrol 34:418-28
Ren, Shuyu; Duffield, Jeremy S (2013) Pericytes in kidney fibrosis. Curr Opin Nephrol Hypertens 22:471-80
Sakai, Norihiko; Chun, Jerold; Duffield, Jeremy S et al. (2013) LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation. FASEB J 27:1830-46
Duffield, Jeremy S; Grafals, Monica; Portilla, Didier (2013) MicroRNAs are potential therapeutic targets in fibrosing kidney disease: lessons from animal models. Drug Discov Today Dis Models 10:e127-e135

Showing the most recent 10 out of 50 publications